Trial Profile
A Prospective Phase I Study to Evaluate the Safety of a Single Intra-articular Injection of Ampion™ as a Treatment for Arthritis of the Basal Thumb Joint
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs DMI 9523 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Ampio Pharmaceuticals
- 11 Nov 2016 Status changed from active, no longer recruiting to completed.
- 04 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
- 29 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016